🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A recent survey conducted by Chemist+Druggist in partnership with @curaleaflabs provides key insights into how pharmacy professionals in the UK perceive medical cannabis, its role in patient care, and the challenges to address to expand safe access. Key insights from the survey

Curaleaf International is growing and we're looking for talented individuals to join our team. Check out a range of new job opportunities across the UK👇 Group Management Accountant | Curaleaf International, London: We're searching for a passionate and meticulous Group

4/20 is more than a date. It's a moment. A moment to reflect on how far we’ve come and how far we still have to go. At Curaleaf International, we see 4/20 as a global opportunity to pause, reflect, and reaffirm our mission: to expand access quality, research-backed medical

We’ve received EU Medical Device Certification for the first handheld liquid inhalation device for medical cannabis—registered in collaboration Jupiter Research A big win for patients. A milestone for Curaleaf International. 🔗 shorturl.at/jvyNq #CannabisInnovation

Jupiter Research and Curaleaf International , just secured EU Medical Device Certification for Europe’s First Handheld Liquid Inhalation Device 🎉 See today’s press release here: tiltholdings.com/investors/news…

We’re officially live in Australia with a range of medical cannabis products! 🇦🇺 Curaleaf International has launched four flower strains in partnership with Canngea . A major step forward in expanding patient access in this fast-growing market — with more innovation to come.

This week, we are supporting Mental Health Awareness Week, focusing on the vital theme of Community. 🌱 According to World Health Organization (WHO) 1 in 8 people worldwide live with a mental health disorder. They are our colleagues, our friends, family and neighbours. We know community plays a crucial

ICYMI: Big week for Curaleaf International! 🌱 🚀 EU certification for the first handheld liquid inhaler with @Jupiter Research Read more: shorturl.at/xYn9C 🇬🇧 Launched new medical cannabis range in Australia Read more: shorturl.at/bUy15 We’re raising the bar for

Curaleaf International welcomes the London Drugs Commission’s landmark report calling for a more evidence-based, public health-led approach to cannabis in the UK. We agree: no one should be criminalised for personal use—especially when managing medical conditions. But

Proud to be featured in Forbes as a leader in Europe’s rapidly growing medical cannabis sector. Europe holds significant opportunities for sustainable growth and expanding access to high-quality cannabis medicines for millions of patients. Our Head of International, Juan

A SIC Notícias report confirms Portugal's status as one of the global export leaders, with 32 tonnes expected this year. Our General Manager of Iberia at Curaleaf International, Nuno Mendonça, shared perspectives on the country's favourable conditions for cultivation and

We’re thrilled to be shortlisted for SIX Business of Cannabis Awards! After taking home five wins last year, it’s an incredible honour to once again be recognised for our continued impact across the cannabis industry. Shortlisted in the following categories: 🏆 European

🏆A Double Win – Business of Cannabis Awards 🏆 We’re honoured to have taken home two awards this year: 🌍 European Cannabis Company of the Year – retaining the title for the second year! 👥 Cannabis Team of the Year – for our incredible team at Four 20 Pharma These awards are a powerful

Show Your Pride at Curaleaf International 🏳️‍🌈 June was the time to honour the LGBTQIA+ community, celebrating identity, diversity, and inclusion. Pride is a celebration and important reminder of the ongoing fight for equality. At Curaleaf, we're committed to fostering a

This year’s global cannabis research symposium CannabinoidSociety held in Indiana, US, provided an opportunity for leading researchers to share their work and learn about the latest developments in cannabinoid science. Recognised for a range of published research, Simon Erridge,